Butein at 10 μg/ml for 5 minutes reduced ROS levels in almost all breast cancer cell lines, whereas it did not affect those in luminal HER2+ HCC-1419, HCC-2218 and SKBR-3 cells (Figure 3A and B). This evidence concerns the gene ERBB2 and breast carcinoma.